In another study, Yang Y. and colleagues fabricated a novel class of bone-targeting anabolic compound based on PTH-PEG-BP (parathyroid hormone- polyethylene glycol-bisphosphonate) for the treatment of osteoporosis and related bone disorders. This evidence concerns the gene PTH and osteoporosis.